CGEM Cullinan Therapeutics
- 27.720
- -1.630-5.55%
- 27.190
- -0.530-1.91%
Cullinan Therapeutics News
Investor Sentiment Swings in Favor of Cullinan Therapeutics (NASDAQ:CGEM)
Cullinan Oncology Initiated at Buy by Stifel
Cullinan Oncology Initiated at Buy by Stifel
Cullinan Therapeutics (CGEM.US) was first covered by Stifel, giving it a buy rating, with a target price of $40.00.
Cullinan Therapeutics (CGEM.US) was first covered by Stifel, giving it a buy rating, with a target price of $40.00.
Stifel Initiates Coverage On Cullinan Therapeutics With Buy Rating, Announces Price Target of $40
Stifel analyst Bradley Canino initiates coverage on Cullinan Therapeutics (NASDAQ:CGEM) with a Buy rating and announces Price Target of $40.
Cullinan Therapeutics Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/01/2024 49.53% Stifel → $40 Initiates Coverage On → Buy 04/17/2024 -2.8% JonesTrading $22 → $26 Maintai
Cullinan Therapeutics Appoints Mary Kay Fenton as CFO
Cullinan Therapeutics (CGEM) said Monday it has appointed Mary Kay Fenton as chief financial officer, effective immediately. Fenton has thirty years of financial and operational experience in the biot
Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Clever Leaves Holdings Inc. (NASDAQ:CLVR) fell sharply during Monday's session after the company announced that it will voluntarily delist its common shares from the Nasdaq and deregister it
Tesla, Deciphera Pharmaceuticals, Heartland Financial And Other Big Stocks Moving Higher On Monday
U.S. stocks were higher, with the Nasdaq Composite jumping over 50 points on Monday.Shares of Tesla, Inc. (NASDAQ:TSLA) rose sharply during Monday's session on reports the company will partner with Ba
Cullinan Therapeutics Appoints CFO
Press Release: Cullinan Therapeutics Announces Appointment of Mary Kay Fenton as Chief Financial Officer
Cullinan Therapeutics Announces Appointment of Mary Kay Fenton as Chief Financial Officer CAMBRIDGE, Mass., April 29, 2024 (GLOBE NEWSWIRE) -- Cullinan Therapeutics, Inc. (Nasdaq: CGEM), a biopharmac
Amgen's Blincyto Data Send Cullinan Higher
Cullinan Therapeutics (NASDAQ:CGEM) drew Wall Street's attention last week as William Blair touted the stock after peer-reviewed data for Amgen's (NASDAQ:AMGN) leukemia therapy, Blincyto, which targets CD19 surface antigens on B cells similar to CGEM's lymphoma candidate CLN-978.
Cullinan Therapeutics Shares Are Trading Higher. The Company This Week Announced That Clinical Data From Its Phase 1 Trial of CLN-619 in Patients With Advanced Solid Tumors Will Be Presented at the 2024 ASCO Annual Meeting.
Cullinan Therapeutics Shares Are Trading Higher. The Company This Week Announced That Clinical Data From Its Phase 1 Trial of CLN-619 in Patients With Advanced Solid Tumors Will Be Presented at the 20
Why Aon Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Shares of Aon plc (NYSE:AON) fell sharply during Friday's session after the company reported worse-than-expected quarterly financial results.Aon posted adjusted earnings of $5.66 per share, missing ma
PEGY, CGEM and IFBD Among Mid-day Movers
Cullinan Therapeutics Up Over 27%, On Pace for Record Percent Increase -- Data Talk
Cullinan Therapeutics, Inc. (CGEM) is currently at $24.48, up $5.23 or 27.17% --Would be highest close since Oct. 15, 2021, when it closed at $25.00 --Would be largest percent increase on record (Ba
12 Health Care Stocks Moving In Friday's Intraday Session
GainersBiodexa Pharmaceuticals (NASDAQ:BDRX) stock rose 61.4% to $1.17 during Friday's regular session. The company's market cap stands at $5.1 million. Agenus (NASDAQ:AGEN) shares rose 32.53% to $11.
Skechers Reports Upbeat Earnings, Joins Tutor Perini, AppFolio, Newell Brands And Other Big Stocks Moving Higher On Friday
U.S. stocks were higher, with the Dow Jones jumping over 150 points on Friday.Shares of Skechers U.S.A., Inc. (NYSE:SKX) rose sharply during Friday's session after the company reported better-than-exp
Why Is Cullinan Therapeutics Stock Trading Higher On Wednesday?
A recent academic case study, published on April 22, examined using Amgen Inc's (NASDAQ:AMGN) Blincyto, a bispecific CD3xCD19 T-cell engager, to treat a patient with severe systemic sclerosis. The fin
Cullinan Therapeutics Shares Are Trading Higher After the Company Announced That Clinical Data From Its Phase 1 Trial of CLN-619 in Patients With Advanced Solid Tumors Will Be Presented at the 2024 ASCO Annual Meeting.
Cullinan Therapeutics Shares Are Trading Higher After the Company Announced That Clinical Data From Its Phase 1 Trial of CLN-619 in Patients With Advanced Solid Tumors Will Be Presented at the 2024 AS
Hilton Worldwide Reports Upbeat Results, Joins Hasbro, Vertiv Holdings And Other Big Stocks Moving Higher On Wednesday
U.S. stocks were mixed, with the Dow Jones falling over 100 points on Wednesday.Shares of Hilton Worldwide Holdings Inc. (NYSE:HLT) rose sharply during Wednesday's session after the company reported b
Analysis
Price Target
No Data
